1. Signaling Pathways
  2. Cell Cycle/DNA Damage
    Metabolic Enzyme/Protease
    Vitamin D Related/Nuclear Receptor
  3. PPAR
  4. PPAR Inhibitors

PPAR Inhibitors

PPARα

PPARβ/δ

PPARγ

PPAR

PPARδ

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

PPAR Inducers, Ligands, Inhibitors, Agonists, Antagonists, Activators & Modulators
Product Name PPARα PPARβ/δ PPARγ PPAR PPARδ Purity
Retinoic acid
PPARα, Kd: 103 nM
PPARα, IC50: 14 nM
PPARβ/δ, Kd: 17 nM
RARβ, IC50: 14 nM
PPARγ, Kd: 178 nM
PPARγ, IC50: 14 nM
    99.81%
Rosiglitazone    
PPARγ, Kd: 40 nM
PPARγ, EC50: 60 nM
    99.94%
GW9662
PPARα, IC50: 32 nM
PPARδ, IC50: 2000 nM
PPARγ, IC50: 3.3 nM
    99.79%
Pioglitazone
hPPARα, EC50: 100 μM
mouse PPARα, EC50: 100 μM
hPPARδ, EC50: 43 μM
hPPARγ, EC50: 0.93 μM
mouse PPARγ, EC50: 0.99 μM
    99.89%
Fenofibrate
PPARα, IC50: 30 μM
        99.97%
Anandamide      
PPAR
  ≥99.0%
1,1'-(Azodicarbonyl)-dipiperidine
PPARα
 
PPAR-γ
 
PPARδ
GW6471
PPARα
        99.64%
5-Aminosalicylic Acid    
PPARγ
    99.82%
Pirinixic acid
PPARα, EC50: 0.63 μM
 
PPARγ, EC50: 32 μM
    98.81%
Troglitazone    
PPARγ, EC50: 550 nM (Human PPARγ)
    99.78%
T0070907
PPARα, Ki: 0.85 μM
PPARδ, Ki: 1.8 μM
PPARγ, Ki: 1 nM
    99.98%
Astaxanthin    
PPARγ
    ≥98.0%
Daidzein
PPAR-α
 
PPAR-γ
    99.72%
Icariin
PPARα
        99.06%
GW7647
PPARα, EC50: 6 nM (Human PPARα)
PPARδ, EC50: 6.2 μM (Human PPARδ)
PPARγ, EC50: 1.1 μM (Human PPARγ)
    99.45%
GW 501516  
PPARδ, EC50: 1.1 nM
      99.43%
Elafibranor
PPAR-α, EC50: 45 nM
PPAR-δ, EC50: 175 nM
      99.32%
GW1929    
PPAR-γ, pEC50: 8.56 (Human PPAR-γ)
    99.93%
Oleuropein    
PPARγ
    99.05%
Glabridin    
PPARγ, EC50: 6.1 μM
    99.98%
Bezafibrate
hPPARα, EC50: 50 μM
hPPARδ, EC50: 20 μM
hPPARγ, EC50: 60 μM
    99.83%
Pioglitazone hydrochloride
PPARα, EC50: 0.93 μM (Human PPARα)
PPARδ, EC50: 0.01 μM (Human PPARδ)
PPARγ, EC50: 43 μM (Human PPARγ)
    99.97%
Magnolol    
PPARγ, EC50: 17.7 μM
    99.84%
Fucoxanthin
PPARα
 
PPARγ
    98.99%
GW0742
PPARα, EC50: 1.1 μM
PPARδ, EC50: 1 nM
PPARγ, EC50: 2 μM
    99.94%
Oleoylethanolamide
PPAR-α
        99.94%
Palacaparib      
PPAR
  99.11%
GSK3787  
PPARδ, pIC50: 6.6 nM
      98.03%
Gemfibrozil
PPAR-α
        99.91%
FH535      
PPAR
  98.72%
Rosiglitazone maleate    
PPARγ1, EC50: 30 nM
PPARγ2, EC50: 100 nM
    99.88%
GSK0660  
PPARβ/δ, IC50: 155 nM
      99.19%
1-Methyladenosine    
PPAR-γ
    99.21%
CDDO-Im
PPARα, Ki: 232 nM
 
PPARγ, Ki: 344 nM
    98.47%
Palmitelaidic Acid
PPARα
        ≥99.0%
Pemafibrate
h-PPARα, EC50: 1 nM
PPARδ, EC50: 1.58 μM
h-PPARγ, EC50: 1.1 μM
    99.85%
Candesartan    
PPAR-γ
    98.03%
Retinoic acid (Standard)
PPARα
PPARβ/δ
RARβ
PPARγ
   
1,2-DLPC
PPARα
        ≥98.0%
FX-909    
PPARγ
    98.80%
Chiglitazar
PPARα, EC50: 1.8 μM
PPARδ, EC50: 1.7 μM
PPARγ, EC50: 0.08 μM
    98.81%
Eupatilin
PPARα
        98.90%
Seladelpar
PPAR-α, EC50: 1600 nM
PPAR-δ, EC50: 2 nM
      99.75%
15-Deoxy-Δ-12,14-prostaglandin J2    
PPARγ, EC50: 2 μM
    ≥99.0%
Bavachinin
PPARα, IC50: 21.043 μM
PPARδ, IC50: 12.819 μM
PPAR-γ, IC50: 0.622 μM
    99.95%
Fenofibric acid
PPARα, EC50: 22.4 μM
PPARδ, EC50: 1.06 μM
PPARγ, EC50: 1.47 μM
    99.94%
Alpinetin    
PPAR-γ
    99.51%
Rosiglitazone hydrochloride    
PPARγ, EC50: 60 nM
PPARγ, Kd: 40 nM
    99.81%
Seladelpar sodium salt  
PPAR-δ, EC50: 2 nM
      98.77%
Fmoc-leucine    
PPARγ
    99.91%
Saroglitazar
PPARα, EC50: 0.65 pM (HepG2 cell)
 
PPARγ, EC50: 3 nM (HepG2 cell)
    99.10%
Clofibrate
PPARα, EC50: 50 μM
 
PPARγ, EC50: 500 μM
    99.61%
Agrimol B    
PPARγ
    99.75%
SR1664    
PPAR-γ, IC50: 80 nM
    ≥98.0%
Ginsenoside Rh1    
PPAR-γ
    ≥98.0%
Bilobetin
PPARα
        99.39%
Avicularin    
PPARγ
    99.80%
Ophiopogonin D
PPARα
        99.54%
Cefminox sodium    
PPARγ
    99.83%
Norathyriol
PPARα, IC50: 92.8 μM
PPARβ, IC50: 102.4 μM
PPARγ, IC50: 153.5 μM
    99.83%
DG172 dihydrochloride  
PPARβ/δ, IC50: 27 nM
      99.35%
Oroxin A    
PPARγ
    99.76%
4-O-Methyl honokiol    
PPARγ
    98.18%
NXT629
hPPARα, IC50: 77 nM
hPPARδ, IC50: 6 μM
hPPARγ, IC50: 15 μM
    99.07%
Ertiprotafib
PPARα, EC50: ~1 μM
PPARβ, EC50: ~1 μM
      98.86%
Hexadecanamide
PPARα
       
Mifobate    
PPARγ, IC50: 140 μM
    99.10%
MTX-531    
PPARγ, EC50: 3.4 μM
    99.87%
BAY-4931    
PPAR-γ, IC50: 0.17 nM (RT112-FABP4-NLucP cellular reporter assay)
mouse PPARγ, IC50: 0.14 nM (GAL4-NHR-LBD one hybrid reporter assay )
hPPARγ, IC50: 0.40 nM (GAL4-NHR-LBD one hybrid reporter assay )
    98.83%
Ciprofibrate
PPARα
        99.93%
PPARα/γ agonist 1
PPARα, EC50: 28 nM
 
PPARγ, EC50: 69 nM
    99.68%
Licarin B    
PPARγ
    99.93%
AMG131    
PPARγ
    99.64%
Glabrone    
PPAR-γ
    99.08%
Gypenoside XLIX
PPAR-α
        99.15%
Leriglitazone hydrochloride    
PPAR-γ, EC50: 9 μM
    99.64%
BMS-687453
PPARα, IC50: 260 nM (Human PPARα)
        99.31%
Raspberry ketone
PPAR-α
        99.91%
PPARγ-IN-2    
PPARγ
    99.57%
L-165041  
PPARδ, Ki: 6 nM
PPARγ, Ki: 730 nM
    99.67%
Saroglitazar magnesium
PPARα, EC50: 0.65 pM (HepG2 cell)
 
PPARγ, EC50: 3 nM (HepG2 cell)
    98.85%
GSK1820795A    
hPPARγ, EC50: 0.25 μM
mouse PPARγ, EC50: 0.27 μM
    99.76%
Etrinabdione    
PPARγ
    99.16%
Darglitazone    
PPAR-γ
    99.19%
HWL-088  
PPARδ, EC50: 570.9 nM
      98.61%
Leriglitazone    
PPAR-γ, EC50: 9 μM
    99.23%
Indeglitazar
PPARα
PPARδ
PPARγ
    99.11%
BAY-0069    
hPPARγ, IC50: 6.3 nM
mouse PPARγ, IC50: 24 nM
    98.07%
Daidzein (Standard)
PPAR-α
 
PPAR-γ
    99.46%
Balaglitazone    
PPARγ, EC50: 351 nM (Human PPARγ)
    99.74%
Adelmidrol    
PPARγ
    ≥98.0%
Drupanin
PPARα, EC50: 39.0 μM
 
PPARγ, EC50: 14.6 μM
    98.05%
LT175
hPPARα, EC50: 0.22 μM
mPPARα, EC50: 0.26 μM
 
hPPARγ, EC50: 0.48 μM
    99.79%
Lobeglitazone
PPARα, EC50: 546.3 nM
 
PPARγ, EC50: 137.4 nM
   
SR 16832    
PPARγ
    99.89%
GW 9578
mouse PPARα, EC50: 5 nM
h-PPARα, EC50: 50 nM
        99.6%
CUDA
PPARα
        ≥98.0%
Aleglitazar
PPARα, IC50: 38 nM
 
PPARγ, IC50: 19 nM
    99.74%
FTX-6746    
PPARγ
    98.68%
Inolitazone dihydrochloride    
PPARγ
    98.86%
(10E,12Z)-Octadeca-10,12-dienoic acid
PPARα
        99.10%
CP-868388 free base
hPPARα, Ki: 10.8 nM
 
hPPARγ, Ki: 3.47 μM
    99.66%
Methyl oleanonate    
PPARγ
    99.81%
Azemiglitazone potassium    
PPAR-γ, IC50: 18.25 μM
    99.53%
F44-A13
PPARα
PPARβ
     
Fenofibrate (Standard)
PPARα
        99.91%
FK614    
PPAR-γ
    99.97%
Falcarindiol    
PPARγ
    99.48%
Lobeglitazone sulfate
PPARα, EC50: 546.3 nM
 
PPARγ, EC50: 137.4 nM
    99.63%
Edaglitazone
PPARα, EC50: 1053 nM
 
PPARγ, EC50: 35.6 nM
    99.58%
Fenofibric acid (Standard)
PPARα
PPARδ
PPARγ
    99.16%
ST247  
PPARβ/δ
      99.88%
25-Hydroxytachysterol3    
PPARγ
    98.89%
1-O-Hexadecylglycerol    
PPAR-γ
    ≥98.0%
SR 11023    
PPARγ, IC50: 108 nM
    99.55%
H-​Trp-​Glu-​OH    
PPARγ, Kd: 8 μM
    99.95%
PPARγ phosphorylation inhibitor 1    
PPARγ, IC50: 24 nM
    99.81%
BAY-5094    
PPAR-γ
    98.04%
MA-0204  
PPARδ, EC50: 0.4 nM (in human)
PPARδ, EC50: 7.9 nM (in mouse)
PPARδ, EC50: 10 nM (in rat)
      99.31%
Gancaonin L    
PPAR-γ
   
MRL-24    
PPARγ
   
Netoglitazone
PPARα
 
PPARγ
    99.88%
10-Nitrolinoleic acid    
PPARγ, IC50: 0.22 μM
   
Clofibrate (Standard)
PPARα
 
PPARγ
    98.09%
SDPC    
PPARγ
   
Angeloylgomisin H    
PPAR-γ
    99.79%
Gemfibrozil (Standard)
PPAR-α
        99.90%
PPARγ agonist 14    
PPARγ, EC50: 2.4 μM
   
13-Oxo-9E,11E-octadecadienoic acid
PPARα
       
GSK376501A    
PPARγ
    99.06%
(±)4-HDHA    
PPARγ
    99.05%
Arhalofenate    
PPAR-γ
   
PPAR agonist 1
PPARα
 
PPARγ
    98.39%
Rosiglitazone potassium    
PPARγ, Kd: 40 nM
PPARγ, EC50: 60 nM
   
Pparδ agonist 5        
PPARδ, EC50: 0.335 μM
Seladelpar Lysine dihydrate        
PPARδ, EC50: 2 nM
≥98.0%
Pioglitazone potassium
hPPARα, EC50: 100 μM
mouse PPARα, EC50: 100 μM
hPPARδ, EC50: 43 μM
mouse PPARγ, EC50: 0.99 μM
h-PPARγ, EC50: 0.93 μM
   
9(10)-Nitrooleate
PPARα
PPARβ/δ
PPARγ
   
PPARα/δ agonist 2
PPARα, EC50: 3255 nM
PPARβ/δ, EC50: 1475 nM
     
Ciprofibrate impurity A
PPARα
       
BMS711939
hPPARα, IC50: 4 nM
 
hPPARγ, IC50: 4.5 μM
   
MBX-102 acid    
PPARγ
   
Tibesaikosaponin V    
PPARγ
   
PPARγ-IN-3    
PPARγ
   
PPAR agonist 4
PPARα, EC50: 0.7 μM
 
PPARγ, EC50: 1.8 μM
 
PPARδ, EC50: 0.7 μM
LJ570
PPARα, EC50: 1.05 μM
 
PPARγ, EC50: 0.12 μM
   
PPARγ/δ modulator 2    
PPARγ
 
PPARδ
Caulophyllogenin    
PPARγ, EC50: 12.6 μM
   
Pparδ agonist 1  
PPARδ, EC50: 5.06 nM
     
Darglitazone Sodium    
PPAR-γ
   
Rac-Pemafibrate
h-PPARα, EC50: 1 nM
h-PPARδ, EC50: 1.7 μM
     
PPARγ/δ modulator 1    
PPARγ, Ki: 5.31 μM
 
PPARδ, Ki: 14.4 nM
Imiglitazar
PPARα, EC50: 67 nM
 
PPARγ1, EC50: 31 nM
   
GW1929 hydrochloride    
hPPARγ, pKi: 8.84
   
Fonadelpar  
PPARδ
     
Icariin (Standard)
PPARα
       
Cinoxate    
PPARγ, Ki: 18 μM
   
Cevoglitazar
PPARα
 
PPARγ
   
Pparδ agonist 2  
PPARδ
     
PPARγ agonist 16    
PPAR-γ, IC50: 1790 nM
   
Apo-12'-lycopenal    
PPAR-γ
   
KD-3010  
PPARδ
     
PPARγ agonist 8    
PPARγ
   
Eupatilin (Standard)
PPARα
       
DS-6930    
PPARγ, EC50: 41 nM
   
Romazarit
PPARα
       
Ginsenoside Rh1 (Standard)    
PPAR-γ
   
PPARα/δ agonist 1
PPARα, EC50: 7 nM
 
PPARγ, EC50: 1316.1 nM
 
PPARδ, EC50: 8.4 nM
SR2595    
PPARγ, IC50: 30 nM
   
PPARδ agonist 10        
PPARδ, EC50: 0.053 μM (hPPARδ)
PPARδ, EC50: 0.30 μM (mPPARδ)
PPARγ modulator-1    
PPAR-γ
   
L-783483        
PPARδ
PPARδ agonist 11
hPPARα, EC50: 8 μM
hPPARδ, EC50: 0.02 μM
     
PPARγ agonist 2    
PPARγ
   
PPARα/δ agonist 3
PPARα, IC50: 5.6 nM
 
PPARγ, IC50: 1278 nM
 
PPARδ, IC50: 3.4 nM
CAY10410    
PPARγ
   
Mesalamine impurity P      
PPAR
 
15-LOX-IN-2    
PPARγ
   
GW7845    
PPARγ
   
PPAR agonist 5
PPARα, EC50: 3.20 μM
PPARβ/δ, EC50: 1.51 μM
PPARγ, EC50: 1.92 μM
   
ZLY06    
PPARγ, IC50: 237 nM
 
PPARδ, IC50: 341 nM
PPARα agonist 1
hPPARα
       
4,5-DiHDPA lactone    
PPARγ
   
Amezalpat
PPARα, IC50: 58 nM
       
E0924G  
PPARδ, EC50: 2.82 μM
     
PPARγ-IN-5    
PPARγ
   
Glabridin (Standard)    
PPARγ
   
YGT-31    
PPARγ, IC50: 1.72 μM
PPARγ, Ki: 0.62 μM
   
PPARγ/GR modulator 1    
PPARγ, Ki: 3.3 μM
   
Avicularin (Standard)    
PPARγ
   
PPARα/γ agonist 2
PPARα, EC50: 0.95 μM
 
PPARγ, EC50: 0.91 μM
   
SKLB102    
PPAR-γ
   
PPARα/γ agonist 4
PPARα
 
PPAR-γ
   
PPARγ modulator-2    
PPARγ, IC50: 41 nM
   
DSO-5a    
PPARγ
   
Chiglitazar sodium
PPARα, EC50: 1.8 μM
PPAR-δ, EC50: 1.7 μM
PPAR-γ, EC50: 0.08 μM
   
Elaidyl-sulfamide
PPARα
       
Rosiglitazone sodium    
PPARγ1, EC50: 30 nM
PPARγ2, EC50: 100 nM
   
Prostaglandin A3    
PPAR-γ, Ki: 188 μM
   
PT-S58  
PPARβ/δ, IC50: 98 nM
     
Prostaglandin B3    
PPARγ
   
Sitofibrate
PPAR-α
       
AZD4619
PPARα
       
T2384    
PPARγ
   
SR-1903    
PPARγ, IC50: 209 nM
   
Inolitazone    
PPARγ
   
17-Oxo-7(Z),10(Z),13(Z),15(E),19(Z)-docosapentaenoic acid    
PPARγ
   
GW 2433
PPARα
     
PPARδ
ZINC17167211
PPAR-α, EC50: 0.16 nM
       
TZD18
hPPARα, IC50: 0.028 μM
 
hPPARγ, IC50: 0.057 μM
 
PPARδ, IC50: >10 μM
AVE-8134
PPARα, EC50: 100 nM (Human PPARα)
       
GW409544
PPARα, EC50: 2.3 nM
 
PPAR-γ, EC50: 0.28 nM
   
CLX-0921    
PPARγ, IC50: 1.54 μM
   
N-Octadecyl-N'-propyl-sulfamide
PPARα
       
NS-220
PPARα, EC50: 19 nM
 
PPARγ, EC50: 9.6 μM
 
PPARδ, EC50: >1 mM
PPARα agonist 2
PPARα, EC50: 37 nM
       
PPARα-MO-1
PPARα